Log in

Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objective

To construct recombinant Lactococcus lactis (L. lactis) expressing viral protein 1 (VP1) of enterovirus 71 (EV71) and evaluate its immunogenicity to be used as an oral vaccine in BALB/c mice.

Results

Recombinant L. lactis competent in secreting VP1 (~ 30 kDa) into the extracellular environment with the aid of the signal peptide Usp45 was produced. Enzyme-linked immunosorbent assay showed that significant VP1-specific antibody response including the production of both serum IgG and fecal IgA (p < 0.05) was elicited in BALB/c mice upon oral immunization with recombinant L. lactis. Moreover, in contrast to negative control, recombinant L. lactis induced adequate neutralizing antibodies in mouse sera (p < 0.05) as demonstrated in virus neutralization assay, whereas the presence of neutralizing antibodies in fecal samples was obvious but not significant (p > 0.05).

Conclusions

Recombinant L. lactis expressing VP1 of EV71 has the potential to be used as an oral vaccine candidate. The findings may provide some preliminary evidences for further development of effective and needle-free EV71 vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Thailand)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D (2014) Antiviral potential of lactic acid bacteria and their bacteriocins. Probiotics Antimicrob Proteins 6:177–185

    Article  CAS  PubMed  Google Scholar 

  • Cano-Garrido O, Seras-Franzoso J, Garcia-Fruitos E (2015) Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb Cell Fact 14:137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao F, Wang Y, Mao Q, Yao X, Liu S, Li F, Zhu F, Yang J et al (2012) Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virol J 9:26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ku Z, Ye X, Shi J, Wang X, Liu Q, Huang Z (2015) Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol 89:12084–12095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee MS, Chang LY (2010) Development of enterovirus 71 vaccines. Expert Rev Vaccines 9:149–156

    Article  CAS  PubMed  Google Scholar 

  • Li L, Qiao X, Chen J, Zhang Y, Zheng Q, Hou J (2018) Surface-displayed porcine reproductive and respiratory syndrome virus from cell culture onto gram-positive enhancer matrix particles. J Ind Microbiol Biotechnol 45:889–898

    Article  CAS  PubMed  Google Scholar 

  • Mao QY, Wang Y, Bian L, Xu M, Liang Z (2016) EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines 15:599–606

    Article  CAS  PubMed  Google Scholar 

  • Peng X, Fang X, Li J, Kong L, Li B, Ding X (2016) Enhancing immune responses of EV71 VP1 DNA vaccine by co-inoculating plasmid IL-12 or GM-CSF expressing vector in mice. Cell Mol Biol 62:35–41

    Article  CAS  PubMed  Google Scholar 

  • Ventarola D, Bordone L, Silverberg N (2015) Update on hand-foot-and-mouth disease. Clin Dermatol 33:340–346

    Article  PubMed  Google Scholar 

  • Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W et al (2012) A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol 19:424–429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK (2015) Lactic acid bacteria–20 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol 99:2967–2977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY (2017) Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res 6:4–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yuan J, Tang X, Yin K, Tian J, Rui K, Ma J, Mao C, Chen J et al (2015) GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity. Immunol Res 62:81–88

    Article  CAS  PubMed  Google Scholar 

  • Zhou BY, Sun JC, Li X, Zhang Y, Luo B, Jiang N, Liu MC (2018) Analysis of immune responses in mice orally immunized with recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis vaccines of taenia solium. J Immunol Res 2018:9262631

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Key Scientific Research Project of Universities of Henan Province, China (Grant Nos. 19A330004 and 18B360012).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pengwei Xu.

Ethics declarations

Conflicts of interest

All authors declared that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, P., Wang, Y., Tao, L. et al. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice. Biotechnol Lett 41, 867–872 (2019). https://doi.org/10.1007/s10529-019-02695-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-019-02695-1

Keywords

Navigation